Clinical Trials List
2025-03-01 - 2028-09-01
Phase III
Recruiting3
ICD-10L73.2
Hidradenitis suppurativa
ICD-9705.83
Hidradenitis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chun-Bing Chen Division of Dermatology
- Chung-Yao Hsu Division of Dermatology
- 吳吉妮 Division of Dermatology
- Chun-Wei Lu Division of Dermatology
- Yu-Huei Huang Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈宜萱 Division of Dermatology
- TSEN-FANG TSAI Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林尚宏 Division of Dermatology
- Chih-Hung Lee Division of Dermatology
- 鄭裕文 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
555 participants
